Clinical Trial

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Name: Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool. — clinical trial record (NCT05245136)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ALPS

Recruiting

View on ClinicalTrials.gov →

Summary

A prospective observational trial of patients with metastatic cancer of various entities which aims at both clarifying the significance of liquid biopsy and establishing a foundation for translational research.

Trial Details

NCT Number	NCT05245136
Lead Sponsor	University Hospital Augsburg
Conditions	Characteristics Disease, Metastatic Cancer, Solid Tumor
Enrollment	3,000 participants
Start Date	2021-03-29
Primary Completion	2029-11 (estimated)
Study Completion	2030-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-30